ANI Pharmaceuticals logo
ANI Pharmaceuticals
ANIP | NASDAQ
Chart Builder DCF Calculator
$70.89
-$0.55 (-0.77%)
At close: Nov 16, 2026, 4:00 PM ET
$70.84
-$0.05 (-0.07%)
After-hours: Nov 16, 2026, 7:30 PM ET

ANI Pharmaceuticals Company Profile

Company profile explained

Company Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Key Executives

Name Position
Nikhil Lalwani President, Chief Executive Officer & Director
Stephen Carey Senior Vice President of Finance & Chief Financial Officer
Chad Gassert Senior Vice President of Corporate Development & Strategy
Christopher K. Mutz Senior Vice President & Head of Rare Disease
Elizabeth Powell Chief Compliance Officer & Head of Legal of Rare Disease
Irina Rivkind Koffler Vice President of Investor Relations
Krista L. Davis Senior Vice President & Chief Human Resources Officer
Meredith W. Cook Senior Vice President, General Counsel & Corporate Secretary
Muthusamy Shanmugam Head of R&D and COO of New Jersey Operations
Ori Gutwerg Senior Vice President of Generics

Latest SEC Filings

Date Type Title
Oct 30, 2026 4 Filing
Oct 16, 2026 4 Filing
Oct 13, 2026 4 Filing
Sep 30, 2026 4 Filing
Sep 16, 2026 4 Filing
Sep 14, 2026 4 Filing
Sep 14, 2026 4 Filing
Sep 01, 2026 4 Filing
Aug 27, 2026 4 Filing
Aug 27, 2026 3 Filing
View All SEC Filings ➞
ANI Pharmaceuticals
ANI Pharmaceuticals logo
Country United States
IPO Date May 5, 2000
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 970
CEO Nikhil Lalwani

Contact Details

210 Main Street West Baudette, Minnesota 56623 United States

Stock Details

Ticker Symbol ANIP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001023024
CUSIP Number 00182C103
ISIN Number US00182C1036
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.